$BMA

Brito Marcos purchased $102K of BMA

Brito Marcos purchased 1,500 shares of Macro Bank Inc. (BMA) at $68.27 ($0.10M total) on 2026-03-19.

Original reporting
SEC EDGAR · Brito Marcos
Published Sep 16, 2026, 9:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 9:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BMA
Neutral
high confidence
Mentioned
$BMA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BMANeutralLow
01

Why it matters

The director's modest buy adds a small amount of insider confidence but is unlikely to affect market perception.

02

Market read

New insider purchase filing; low material impact but useful for tracking insider sentiment.

03

What to watch

Potential upcoming regulatory or earnings events that may later influence insider behavior.

Relevance 5/10Novelty 5/10Timing: filed 2026-09-16

Background

SEC Form 4 filing discloses insider transactions. Macro Bank Inc. (BMA) is a US‑listed financial services company.

Company-level read

Ticker impact

$BMANeutralHigh confidence
Context

Director Brito Marcos bought 1,500 shares of Macro Bank Inc. at $68.27 each, total $102,399.

Expected impact

Minimal short-term impact; price likely unchanged.

Evidence & confidence

The transaction size is modest relative to market cap and represents a typical 10b5-1 purchase.

Market effects

Limited; reflects typical insider activity in financial services.

None; only affects Macro Bank shareholders.

Low; no broader market effect.

Counterpoint

The purchase could be a routine portfolio rebalancing, not a confidence signal.

Key entities

  • Macro Bank Inc.

    Issuer of the Form 4 filing.

  • Brito Marcos

    Director of Macro Bank Inc. who made the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$YPFHighAI 8/10

Argentina Markets: Merval & the Peso — September 10, 2026

Argentina's S&P Merval index rose 1.11% to 3,110,163, up 30.5% year-on-year. YPF, the state-linked oil and gas company, led gains with a 3.6% increase after raising $1.2bn in international debt. Banks also performed well, reflecting confidence in President Milei's economic reforms. The peso slipped 0.13% to 1,514 per dollar, near its 52-week high.

$BMAMed

Banco Macro Announces Results for the Second Quarter of 2026

Banco Macro reported 2Q26 net income of Ps.206.8 billion, up 39% from the previous quarter and 4% year-over-year. Operating income before expenses was Ps.1.29 trillion, down 2% quarter-over-quarter but up 1% year-over-year. The bank's total financing increased 3% quarter-over-quarter but decreased 5% year-over-year. Banco Macro maintains strong solvency and liquidity ratios, with excess capital of Ps.4.1 trillion and liquid assets covering 74% of deposits.

$BMAHigh

Macro Bank Inc. (BMA): Financial results for Q2 2026

Macro Bank Inc. (BMA) furnished an SEC Form 6-K — earnings release. Yes o No x 2Q26 Earnings Release AUGUST 19TH, 2026 BANCO MACRO 2Q26 EARNINGS RELEASE 2 Index 01 Summary 02 Disclaimer 03 Results 04 Financial Assets 05 Public Sector Assets 06 Funding 07 Liquid Assets 08 Solvency 09 Asset Quality 10 2Q26 Snapshot 11 Relevant and Recent Events 12

$BMAMedAI 8/10

Banco Macro Q1 2026 Earnings Call Transcript - Banco Macro (NYSE:BMA)

Banco Macro reported Q1 2026 net income of 139.8 billion pesos, up 28% quarter-on-quarter and 131% year-on-year, according to the earnings call transcript. Operating income before expenses fell 3% vs. Q4 2025 but rose 15% year-on-year. The bank kept 2026 loan growth guidance at 42% nominal and deposit growth at 34% nominal, assuming 28% inflation. NPL ratio was 5.4% with ~110% coverage; cost of risk guidance is 5.5%–6%.